Atamyo Therapeutics, a biotechnology company specializing in the development of next-generation gene therapies for limb-girdle muscular dystrophy (LGMD), announced at the MDA (Muscular Dystrophy ...
Mutations that cause spinal muscular atrophy (SMA) may lead to abnormalities in the development of cells in the spinal cord, a study found.
Researchers say a regulatory protein found in skeletal muscle fiber may play an important role in the body's fight or flight response when encountering stressful situations. Researchers at the ...